发布求助
文献互助 智能选刊 最新文献

Herzschrittmachertherapie und Elektrophysiologie最新文献

筛选
英文 中文
[Controversies in rhythmology]. [节律学的争议]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-10-14 DOI: 10.1007/s00399-024-01048-4
Victoria Johnson, Philipp Sommer
{"title":"[Controversies in rhythmology].","authors":"Victoria Johnson, Philipp Sommer","doi":"10.1007/s00399-024-01048-4","DOIUrl":"https://doi.org/10.1007/s00399-024-01048-4","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atrial fibrillation in combination with severe mitral regurgitation : Which should be treated first, the atrial fibrillation or the mitral valve?] [心房颤动合并严重二尖瓣返流：应该先治疗心房颤动还是二尖瓣？］
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-27 DOI: 10.1007/s00399-024-01045-7
Nora Köpcke, Fabian Barbieri, Mario Kasner, Markus Reinthaler, Ulf Landmesser, Martin Huemer, Philipp Attanasio
{"title":"[Atrial fibrillation in combination with severe mitral regurgitation : Which should be treated first, the atrial fibrillation or the mitral valve?]","authors":"Nora Köpcke, Fabian Barbieri, Mario Kasner, Markus Reinthaler, Ulf Landmesser, Martin Huemer, Philipp Attanasio","doi":"10.1007/s00399-024-01045-7","DOIUrl":"https://doi.org/10.1007/s00399-024-01045-7","url":null,"abstract":"<p><strong>Background: </strong>The primary therapeutic approach for severe secondary mitral regurgitation (MR) in combination with atrial fibrillation is often not clear.</p><p><strong>Objectives/methods: </strong>To create a therapeutic guideline for daily clinical practice based on a case report as well as basic literature.</p><p><strong>Results: </strong>If a functional component is suspected, restoration of sinus rhythm may lead to a significant improvement in MR. The extent of the improvement and the time required to achieve this improvement are often difficult to predict.</p><p><strong>Conclusions: </strong>The involvement of an electrophysiologist is recommended in order to assess the likelihood of successful long-term rhythm control aimed at improving MR. In unclear cases, cardioversion combined with short-term administration of antiarrhythmic medication may be useful to demonstrate potential improvement of MR in sinus rhythm.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Initial ablation of atrial fibrillation-Is pulmonary vein isolation sufficient? : Pro and contra]. [心房颤动的初始消融--肺静脉隔离是否足够？ 赞成与反对]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-27 DOI: 10.1007/s00399-024-01044-8
Kyoung-Ryul Julian Chun, Sascha Rolf
{"title":"[Initial ablation of atrial fibrillation-Is pulmonary vein isolation sufficient? : Pro and contra].","authors":"Kyoung-Ryul Julian Chun, Sascha Rolf","doi":"10.1007/s00399-024-01044-8","DOIUrl":"https://doi.org/10.1007/s00399-024-01044-8","url":null,"abstract":"<p><p>Pulmonary vein isolation (PVI) is currently the gold standard for the ablation of atrial fibrillation (AF). Although this procedure shows good success rates, the recurrence rates after PVI alone are significantly higher in advanced AF and in the presence of comorbidities. Therefore, it is important to consider additional arrhythmogenic mechanisms outside the pulmonary veins, depending on the individual case, in order to improve the patients' outcome.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[(LV)EF is a poor predictor of sudden cardiac death : Pro/Contra]. (LV)EF是心脏性猝死的不良预测指标：Pro/Contra].
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-10 DOI: 10.1007/s00399-024-01041-x
Christian Butter, Gerd Hindricks
{"title":"[(LV)EF is a poor predictor of sudden cardiac death : Pro/Contra].","authors":"Christian Butter, Gerd Hindricks","doi":"10.1007/s00399-024-01041-x","DOIUrl":"https://doi.org/10.1007/s00399-024-01041-x","url":null,"abstract":"<p><p>For more than two decades the left ventricular ejection fraction (LVEF) has been utilized with practically uncritical absolutism for the risk stratification of patients with ischemic and, historically, also nonischemic cardiomyopathy, in order to identify patients who could be threatened by sudden cardiac death. Based on historical data and in the absence of other better predictive parameters, the LVEF continues to appear in the guidelines unchanged, with cut-off values that lie in the region of the measurement accuracy of LVEF as determined by echocardiography. The basic identification of high-risk patients who then really benefit from an implantable cardioverter defibrillator (ICD) must be re-evaluated under the aspect of a meaningfully altered interventional and pharmaceutical treatment of heart failure.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum zu: Herzrhythmusstörungen bei Erwachsenen mit angeborenen Herzfehlern. 勘误：先天性心脏病成人的心律失常。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-10 DOI: 10.1007/s00399-024-01046-6
Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez
{"title":"Erratum zu: Herzrhythmusstörungen bei Erwachsenen mit angeborenen Herzfehlern.","authors":"Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez","doi":"10.1007/s00399-024-01046-6","DOIUrl":"10.1007/s00399-024-01046-6","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulsed-field ablation-is it the only energy source for ablation in the future? : Pro/Contra]. [脉冲场消融--它是未来消融的唯一能源吗？ : Pro/Contra]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-03 DOI: 10.1007/s00399-024-01035-9
Melanie Gunawardene, Thomas Arentz
{"title":"[Pulsed-field ablation-is it the only energy source for ablation in the future? : Pro/Contra].","authors":"Melanie Gunawardene, Thomas Arentz","doi":"10.1007/s00399-024-01035-9","DOIUrl":"https://doi.org/10.1007/s00399-024-01035-9","url":null,"abstract":"<p><p>Pulsed field ablation (PFA) is a nonthermal energy source used for cardiac ablation procedures. Cell death during PFA occurs via electroporation: ultrarapid (micro- to nanosecond) electrical pulses are applied to destabilize cell membranes causing irreversible pores. PFA leads to preferential ablation of myocardiocytes, sparing adjacent tissue like the esophagus or phrenic nerve. Preliminary clinical studies show high efficacy and a good safety profile in atrial fibrillation patients undergoing pulmonary vein isolation. The question remains, however, whether this new technology will replace well-known and established thermal energy sources like radiofrequency current or cryoablation within the next 5 years.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cardiac arrhythmias in adults with congenital heart disease]. [成人先天性心脏病患者的心律失常]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-03 DOI: 10.1007/s00399-024-01037-7
Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez
{"title":"[Cardiac arrhythmias in adults with congenital heart disease].","authors":"Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez","doi":"10.1007/s00399-024-01037-7","DOIUrl":"10.1007/s00399-024-01037-7","url":null,"abstract":"<p><p>In patients with congenital heart disease, cardiac arrhythmias are complex and require a thorough understanding of the anatomy, past surgical and interventional procedures, and the specific electric processes. Supraventricular tachycardias commonly present as emergency situations and should be treated immediately, particularly when there is an underlying complex malformation. Establishing sinus rhythm is usually superior to pure frequency control for hemodynamic reasons. Catheter ablation should be preferred over medical treatment, even though several procedures are often necessary. In addition, bradycardia is seen more frequently in congenital heart defects; this could be aggravated by antiarrhythmic drugs. There are significant differences between the indications and techniques used for pacemaker implantation in patients with congenital heart defects and those without. Patients with complex congenital heart diseases have an increased risk of thromboembolism; therefore, an individual and early indication for low-threshold oral anticoagulation is necessary; direct oral anticoagulants can also be used for this purpose. In risk stratification for sudden cardiac death, the principles of general guidelines are often not applicable, and individualized decisions are required. Recently, a new general risk score for congenital heart disease has been developed. The treatment of cardiac arrhythmias in patients with congenital heart disease should always be performed in close cooperation with specialized centers.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epicardial ablation of ventricular tachycardia with cardiac surgery only : Pro/Contra]. [心外膜消融室性心动过速，只需进行心脏手术：赞成/反对]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-02 DOI: 10.1007/s00399-024-01038-6
Christian Sohns, Boris Schmidt
{"title":"[Epicardial ablation of ventricular tachycardia with cardiac surgery only : Pro/Contra].","authors":"Christian Sohns, Boris Schmidt","doi":"10.1007/s00399-024-01038-6","DOIUrl":"https://doi.org/10.1007/s00399-024-01038-6","url":null,"abstract":"<p><p>During the ablation of ventricular arrhythmias (VA) complications can occur, albeit rather rarely, and their occurrence depends on various factors. On the one hand the patient's condition and comorbidities play a role, on the other hand the access site and the procedure itself can lead to complications which have to be addressed adequately. This article will discuss whether complex ablations with epicardial access should only be performed at centres with the appropriate expertise and a cardiac surgery department.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Holter monitoring]. [Holter监测]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-08-19 DOI: 10.1007/s00399-024-01036-8
Carsten W Israel, Sona Tribunyan
{"title":"[Holter monitoring].","authors":"Carsten W Israel, Sona Tribunyan","doi":"10.1007/s00399-024-01036-8","DOIUrl":"10.1007/s00399-024-01036-8","url":null,"abstract":"<p><p>Holter monitoring represents a valuable diagnostic tool to document intermittent arrhythmias in the work-up of, for example, syncope, presyncope, collapse, falls, dizziness, stroke, palpitations, and a rapid heartbeat. In addition, it may help in the diagnosis of intermittent ischemia and channelopathies, particularly in the form of 12-lead Holter monitoring. Continuous ECG registration typically lasts from 24-48 h. The use of Holter monitoring is limited in patients with rare symptoms (< 1 × per month) and in recordings full of artifacts. The interpretation of a Holter recording combines an automatic analysis with a manual reassessment. The clinical relevance of many arrhythmias can only be considered together with symptoms and activity of the patient at the time of the event. Therefore, a patient diary accompanying the ECG recording is crucial. Systematic assessment of the ECG recording and knowledge about a number of pitfalls in Holter monitoring can optimize the interpretation of the recording.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The challenge: specialization meets general medicine]. [挑战：专业化与全科医学]。
Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-08-22 DOI: 10.1007/s00399-024-01034-w
Harilaos Bogossian, Sonia Busch
{"title":"[The challenge: specialization meets general medicine].","authors":"Harilaos Bogossian, Sonia Busch","doi":"10.1007/s00399-024-01034-w","DOIUrl":"10.1007/s00399-024-01034-w","url":null,"abstract":"","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信